Trial will test stem cells as cerebral palsy treatment

02/12/2010 | Disability Scoop

Researchers at the Medical College of Georgia are preparing to start the first FDA-approved clinical study of the effectiveness of using umbilical cord-blood stem cells as treatment for cerebral palsy. The trial will involve 40 patients ages 2 to 12. Doctors will examine the patients for improvements three months, six months and nine months into the trial.

View Full Article in:

Disability Scoop

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Fort Worth, TX
Senior Scientist - Cell Engineering Group
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC